| 000 | 01772 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513223617.0 | ||
| 264 | 0 | _c20001222 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0953-816X | ||
| 024 | 7 |
_a10.1046/j.1460-9568.2000.00288.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrömberg, I | |
| 245 | 0 | 0 |
_aElectrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum. _h[electronic resource] |
| 260 |
_bThe European journal of neuroscience _cNov 2000 |
||
| 300 |
_a4033-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDenervation |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 | _aFunctional Laterality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxidopamine _xpharmacology |
| 650 | 0 | 4 |
_aParkinson Disease _xphysiopathology |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
| 650 | 0 | 4 |
_aQuinpirole _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Adenosine A2A |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xphysiology |
| 650 | 0 | 4 | _aReference Values |
| 700 | 1 | _aPopoli, P | |
| 700 | 1 | _aMüller, C E | |
| 700 | 1 | _aFerré, S | |
| 700 | 1 | _aFuxe, K | |
| 773 | 0 |
_tThe European journal of neuroscience _gvol. 12 _gno. 11 _gp. 4033-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1460-9568.2000.00288.x _zAvailable from publisher's website |
| 999 |
_c11011434 _d11011434 |
||